PYRIDOXINE HYDROCHLORIDE

PYRIDOXINE HYDROCHLORIDE was reported 2731 times

PYRIDOXINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 238 0.6150
1 ANTACID THERAPY 57 0.4385
2 SLEEP DISORDER THERAPY 79 0.3990
3 ANALGESIC THERAPY 92 0.2866
4 DRUG THERAPY 86 0.2537
5 ANTICOAGULANT THERAPY 54 0.1901
6 HYPOCHOLESTEROLAEMIA 62 0.1756
7 BACTEROIDES INFECTION 36 0.1379
8 URETHRAL CARUNCLE 9 0.1343
9 CONGENITAL HIATUS HERNIA 24 0.1053
10 PRESBYACUSIS 30 0.0974
11 MALIGNANT MELANOMA STAGE 0 18 0.0861
12 MITOCHONDRIAL DNA DEPLETION 3 0.0857
13 URETERIC RUPTURE 3 0.0811
14 GAIT SPASTIC 27 0.0787
15 BLOOD PHOSPHORUS INCREASED 180 0.0659
16 NEEDLE FATIGUE 27 0.0591
17 HYPERPHOSPHATAEMIA 114 0.0530
18 RECTOURETHRAL FISTULA 3 0.0526
19 PLEURAL THICKENING 30 0.0439
20 BLOOD MAGNESIUM INCREASED 33 0.0366
21 C-REACTIVE PROTEIN 32 0.0345
22 MEIBOMIANITIS 3 0.0333
23 LUPUS VULGARIS 42 0.0333
24 RELAPSING-REMITTING MULTIPLE SCLEROSIS 27 0.0312
25 BONE HYPERTROPHY 5 0.0311
26 FACET JOINT SYNDROME 100 0.0307
27 DELUSION OF REPLACEMENT 3 0.0300
28 PLEURAL FIBROSIS 30 0.0294
29 PERICHONDRITIS 3 0.0291
30 RETINITIS 50 0.0289
31 TOTAL LUNG CAPACITY DECREASED 43 0.0269
32 RUBELLA 3 0.0263
33 APPENDICITIS 240 0.0257
34 PERIPHERAL VENOUS DISEASE 101 0.0247
35 EPIDERMAL NECROSIS 24 0.0246
36 BLOOD URIC ACID INCREASED 138 0.0239
37 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 21 0.0227
38 IRON DEFICIENCY 99 0.0220
39 DISLOCATION OF VERTEBRA 50 0.0219
40 AORTIC STENOSIS 70 0.0201
41 BLEPHAROSPASM 124 0.0197
42 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 10 0.0178
43 VENTRICULAR FIBRILLATION 195 0.0175
44 NECROTISING ENTEROCOLITIS NEONATAL 7 0.0172
45 INSULIN-LIKE GROWTH FACTOR DECREASED 9 0.0170
46 BREAST CANCER STAGE III 105 0.0162
47 CARDIOGENIC SHOCK 231 0.0161
48 BONE CYST 15 0.0160
49 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 81 0.0160
50 MYASTHENIA GRAVIS 125 0.0155
51 LUNG OPACITY 40 0.0152
52 HYPOPHOSPHATAEMIA 112 0.0151
53 MONOPARESIS 27 0.0149
54 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 106 0.0148
55 DUODENAL ULCER PERFORATION 103 0.0138
56 ATROPHIC VULVOVAGINITIS 10 0.0137
57 VAGINAL FLATULENCE 4 0.0132
58 BITE 9 0.0124
59 MUSCLE INJURY 100 0.0121
60 DEEP VEIN THROMBOSIS POSTOPERATIVE 24 0.0120
61 TRACHEAL OBSTRUCTION 3 0.0114
62 FOLLICULITIS 119 0.0113
63 PATIENT ELOPEMENT 4 0.0109
64 LIP DRY 99 0.0109
65 BURSITIS 132 0.0109
66 JEALOUS DELUSION 3 0.0106
67 ADMINISTRATION SITE DISCOMFORT 2 0.0106
68 LIVE BIRTH 88 0.0105
69 MONOCLONAL IMMUNOGLOBULIN INCREASED 3 0.0105
70 ANAEMIA NEONATAL 5 0.0104
71 INFREQUENT BOWEL MOVEMENTS 25 0.0100
72 RHEUMATIC FEVER 44 0.0099
73 HYPERTONIC BLADDER 28 0.0097
74 MUMPS 3 0.0096
75 OSTEOSCLEROSIS 15 0.0095
76 DEAFNESS NEUROSENSORY 31 0.0094
77 SWOLLEN JOINT COUNT INCREASED 30 0.0094
78 RHEUMATOID FACTOR POSITIVE 53 0.0092
79 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 19 0.0092
80 HELICOBACTER INFECTION 93 0.0090
81 PEMPHIGUS 111 0.0089
82 VASCULAR DEVICE OCCLUSION 3 0.0088
83 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 151 0.0088
84 LIGHT CHAIN ANALYSIS INCREASED 9 0.0087
85 BODY TEMPERATURE FLUCTUATION 18 0.0086
86 PERICARDITIS 145 0.0086
87 OVERLAP SYNDROME 6 0.0086
88 NAIL DISORDER 75 0.0086
89 EPIGASTRIC DISCOMFORT 33 0.0084
90 ASCITES 248 0.0084
91 TIME PERCEPTION ALTERED 3 0.0083
92 WOUND INFECTION 90 0.0082
93 MULTIPLE ORGAN DYSFUNCTION SYNDROME 223 0.0079
94 X-RAY ABNORMAL 14 0.0078
95 PORPHYRIA ACUTE 11 0.0077
96 ORAL MUCOSAL DISCOLOURATION 5 0.0075
97 JOINT RANGE OF MOTION DECREASED 101 0.0075
98 C-REACTIVE PROTEIN ABNORMAL 48 0.0075
99 APRAXIA 11 0.0074
100 TROPONIN INCREASED 55 0.0072
101 HYPERTELORISM OF ORBIT 3 0.0072
102 EXOSTOSIS 64 0.0070
103 BACTERIAL INFECTION 130 0.0070
104 SYSTOLIC HYPERTENSION 3 0.0069
105 HAND DEFORMITY 89 0.0068
106 BLOOD CALCIUM INCREASED 59 0.0067
107 DELUSIONAL DISORDER, UNSPECIFIED TYPE 5 0.0067
108 ONYCHOMADESIS 27 0.0064
109 SYNOVITIS 113 0.0063
110 SERONEGATIVE ARTHRITIS 7 0.0061
111 OBESITY 96 0.0060
112 TASTE DISORDER 122 0.0060
113 HYPERLIPIDAEMIA 70 0.0059
114 REGURGITATION 20 0.0058
115 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 3 0.0057
116 INFUSION SITE REACTION 17 0.0057
117 ANAL ATRESIA 3 0.0056
118 ORTHOSTATIC INTOLERANCE 4 0.0056
119 MEASLES 3 0.0056
120 PLEURITIC PAIN 15 0.0054
121 BLOOD CHOLESTEROL INCREASED 253 0.0054
122 RHEUMATOID FACTOR INCREASED 6 0.0054
123 HEPATIC CONGESTION 5 0.0053
124 ALLODYNIA 6 0.0051
125 RED BLOOD CELL SEDIMENTATION RATE INCREASED 56 0.0051
126 IRRITABLE BOWEL SYNDROME 107 0.0050
127 NEURALGIA 121 0.0050
128 MEAN PLATELET VOLUME INCREASED 3 0.0050
129 RESPIRATORY SYMPTOM 14 0.0049
130 VITAMIN B12 DEFICIENCY 19 0.0047
131 BACK INJURY 51 0.0047
132 SKULL MALFORMATION 3 0.0047
133 NASAL CRUSTING 3 0.0046
134 BLOOD IMMUNOGLOBULIN A DECREASED 3 0.0046
135 JOINT DESTRUCTION 7 0.0045
136 GLOSSODYNIA 100 0.0045
137 HYPONATRAEMIA 247 0.0044
138 INCISION SITE PAIN 5 0.0043
139 HYPERCHOLESTEROLAEMIA 41 0.0042
140 LIVER INJURY 101 0.0041
141 FIBROMYALGIA 100 0.0041
142 GAZE PALSY 7 0.0041
143 GOUT 73 0.0041
144 END STAGE RENAL DISEASE 74 0.0041
145 EPILEPSY 124 0.0041
146 WOUND 113 0.0040
147 CARCINOID TUMOUR 3 0.0040
148 INTESTINAL STENOSIS 17 0.0040
149 BONE DENSITY ABNORMAL 15 0.0040
150 LIP DISCOLOURATION 5 0.0040
151 MICTURITION URGENCY 45 0.0039
152 ULCER 62 0.0039
153 PNEUMONIA ASPIRATION 97 0.0039
154 GROWTH OF EYELASHES 3 0.0038
155 BLOOD TEST ABNORMAL 53 0.0038
156 HERPES ZOSTER DISSEMINATED 3 0.0037
157 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 3 0.0037
158 BONE EROSION 13 0.0037
159 MITOCHONDRIAL TOXICITY 3 0.0037
160 OSTEOARTHRITIS 155 0.0037
161 NOCTURIA 43 0.0035
162 LOWER RESPIRATORY TRACT INFECTION 160 0.0035
163 FEMALE GENITAL TRACT FISTULA 6 0.0035
164 BLOOD CHLORIDE DECREASED 9 0.0035
165 BENIGN PROSTATIC HYPERPLASIA 18 0.0035
166 PSORIATIC ARTHROPATHY 140 0.0034
167 RALES 20 0.0034
168 DRY MOUTH 278 0.0034
169 HEAD DISCOMFORT 60 0.0034
170 NIGHT SWEATS 109 0.0034
171 IMPAIRED HEALING 110 0.0033
172 BLOOD SODIUM INCREASED 9 0.0033
173 GENERAL PHYSICAL HEALTH DETERIORATION 384 0.0033
174 BREATH SOUNDS ABNORMAL 16 0.0032
175 GASTROOESOPHAGEAL REFLUX DISEASE 256 0.0032
176 TOXIC EPIDERMAL NECROLYSIS 48 0.0032
177 SYSTEMIC LUPUS ERYTHEMATOSUS 112 0.0032
178 BREAST CANCER STAGE II 26 0.0031
179 VITAMIN B12 DECREASED 9 0.0031
180 GESTATIONAL HYPERTENSION 4 0.0031
181 BLOOD PARATHYROID HORMONE INCREASED 9 0.0031
182 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 2 0.0031
183 CONTRAINDICATED PRODUCT ADMINISTERED 93 0.0031
184 BLOOD IMMUNOGLOBULIN M DECREASED 3 0.0030
185 BRONCHIECTASIS 20 0.0030
186 REDUCED FACIAL EXPRESSION 3 0.0030
187 BLOOD POTASSIUM INCREASED 47 0.0029
188 VERTIGO POSITIONAL 5 0.0029
189 ABDOMINAL DISTENSION 298 0.0029
190 DRUG TOLERANCE DECREASED 8 0.0028
191 JOINT CONTRACTURE 3 0.0028
192 SWELLING 260 0.0028
193 SLEEP DISORDER 196 0.0028
194 ACCOMMODATION DISORDER 2 0.0027
195 OCULAR TOXICITY 3 0.0027
196 CLEFT LIP AND PALATE 3 0.0027
197 CATHETER SITE DISCHARGE 3 0.0027
198 ASPIRATION 29 0.0026
199 TYPE 2 DIABETES MELLITUS 89 0.0026
200 C-REACTIVE PROTEIN INCREASED 95 0.0026
201 LIVER FUNCTION TEST INCREASED 56 0.0026
202 INTRUSIVE THOUGHTS 3 0.0025
203 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 133 0.0025
204 ATAXIA 30 0.0025
205 INFLAMMATION 130 0.0025
206 LUNG DISORDER 122 0.0025
207 DRUG INTOLERANCE 238 0.0025
208 MUSCULOSKELETAL PAIN 129 0.0025
209 STOMATITIS 148 0.0024
210 CYST 30 0.0024
211 ABDOMINAL TENDERNESS 12 0.0024
212 MUSCLE SPASTICITY 29 0.0024
213 OROPHARYNGEAL DISCOMFORT 21 0.0023
214 DYSAESTHESIA 7 0.0023
215 RADICULOPATHY 6 0.0023
216 WHEEZING 134 0.0023
217 SEPSIS 249 0.0022
218 ARTHROPATHY 122 0.0022
219 GRIP STRENGTH DECREASED 19 0.0022
220 FREQUENT BOWEL MOVEMENTS 58 0.0021
221 INFUSION RELATED REACTION 142 0.0021
222 DISCOURAGEMENT 5 0.0021
223 NECK PAIN 119 0.0021
224 BLISTER 119 0.0021
225 OSTEOPENIA 32 0.0021
226 LUPUS-LIKE SYNDROME 19 0.0021
227 COMA 99 0.0021
228 PUSTULAR PSORIASIS 7 0.0020
229 COCCYDYNIA 3 0.0020
230 PERSECUTORY DELUSION 5 0.0020
231 LUNG ADENOCARCINOMA 6 0.0020
232 PARAINFLUENZAE VIRUS INFECTION 3 0.0020
233 CENTRAL NERVOUS SYSTEM LESION 27 0.0020
234 AUTOIMMUNE DISORDER 19 0.0019
235 PULMONARY FIBROSIS 36 0.0019
236 MIGRAINE 179 0.0019
237 OCULOGYRIC CRISIS 4 0.0019
238 INFUSION SITE BRUISING 4 0.0019
239 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 12 0.0018
240 DEFORMITY 17 0.0018
241 DIABETES MELLITUS 138 0.0018
242 PROTEIN URINE PRESENT 9 0.0018
243 BLOOD CALCIUM ABNORMAL 3 0.0018
244 TROPONIN I INCREASED 3 0.0018
245 FULL BLOOD COUNT ABNORMAL 19 0.0018
246 PULMONARY MASS 26 0.0017
247 RASH PAPULAR 39 0.0017
248 BLOOD CHLORIDE INCREASED 3 0.0017
249 IRON DEFICIENCY ANAEMIA 16 0.0017
250 HEPATIC ENZYME INCREASED 118 0.0017
251 INFUSION SITE INFECTION 4 0.0017
252 THROMBOSIS 137 0.0017
253 NYSTAGMUS 9 0.0017
254 SKIN ABRASION 8 0.0017
255 SPUTUM DISCOLOURED 16 0.0017
256 OBSESSIVE THOUGHTS 3 0.0017
257 MATERNAL EXPOSURE DURING PREGNANCY 148 0.0017
258 BLOOD CREATININE INCREASED 108 0.0017
259 FAECES SOFT 12 0.0016
260 SPONDYLITIS 6 0.0016
261 ULCER HAEMORRHAGE 11 0.0016
262 FREEZING PHENOMENON 6 0.0016
263 OBSTRUCTIVE AIRWAYS DISORDER 18 0.0016
264 MUCOUS STOOLS 8 0.0016
265 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
266 LYMPH NODE PAIN 3 0.0016
267 CHRONIC SINUSITIS 6 0.0016
268 NARCOLEPSY 3 0.0016
269 BONE MARROW TRANSPLANT 3 0.0016
270 CONGENITAL ANOMALY 12 0.0015
271 SUSPECTED OFF LABEL USE 7 0.0015
272 INFUSION SITE HAEMORRHAGE 5 0.0015
273 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
274 OTITIS MEDIA 5 0.0015
275 NEPHRITIS 5 0.0015
276 DEVICE RELATED SEPSIS 3 0.0015
277 SHOULDER ARTHROPLASTY 4 0.0015
278 INTENTIONAL PRODUCT MISUSE 129 0.0015
279 CERVICAL VERTEBRAL FRACTURE 5 0.0014
280 RASH VESICULAR 7 0.0014
281 HYPOSPADIAS 3 0.0014
282 ON AND OFF PHENOMENON 8 0.0014
283 CHOLECYSTITIS INFECTIVE 4 0.0014
284 BLOOD PRESSURE SYSTOLIC INCREASED 28 0.0014
285 HYPERREFLEXIA 5 0.0014
286 PROCTITIS 4 0.0014
287 MUSCULOSKELETAL STIFFNESS 125 0.0014
288 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
289 NECK MASS 4 0.0014
290 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 24 0.0014
291 PULMONARY TUBERCULOSIS 6 0.0014
292 ABDOMINAL PAIN 326 0.0014
293 RHEUMATOID ARTHRITIS 159 0.0014
294 HEPATIC STEATOSIS 26 0.0014
295 DEREALISATION 3 0.0014
296 SOMNOLENCE 278 0.0014
297 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
298 ONYCHOMYCOSIS 6 0.0014
299 OSTEOPOROSIS 56 0.0014
300 MEMORY IMPAIRMENT 186 0.0014
301 GASTROINTESTINAL ULCER 3 0.0014
302 DECUBITUS ULCER 11 0.0013
303 SKIN LESION 37 0.0013
304 EAR PAIN 26 0.0013
305 VITAMIN D DEFICIENCY 13 0.0013
306 CONSTIPATION 290 0.0013
307 CHRONIC GASTRITIS 3 0.0013
308 SCIATICA 21 0.0013
309 PULMONARY EMBOLISM 125 0.0013
310 MOBILITY DECREASED 94 0.0013
311 RASH ERYTHEMATOUS 62 0.0013
312 NORMAL NEWBORN 7 0.0013
313 FAECES HARD 5 0.0013
314 RIGHT VENTRICULAR FAILURE 9 0.0013
315 BILIRUBIN CONJUGATED INCREASED 3 0.0013
316 FEELING HOT 78 0.0013
317 VARICELLA 3 0.0013
318 EXPOSURE DURING PREGNANCY 78 0.0013
319 ASPARTATE AMINOTRANSFERASE INCREASED 66 0.0012
320 SKIN EROSION 4 0.0012
321 BLOOD PRESSURE SYSTOLIC ABNORMAL 3 0.0012
322 PENIS DISORDER 3 0.0012
323 SPINAL STENOSIS 5 0.0012
324 PRESCRIBED UNDERDOSE 24 0.0012
325 PRESCRIBED OVERDOSE 23 0.0012
326 DRUG TOLERANCE 6 0.0012
327 THERAPEUTIC PRODUCT EFFECT DECREASED 53 0.0012
328 HYPOAESTHESIA 177 0.0012
329 BLOOD PRESSURE DIASTOLIC ABNORMAL 3 0.0012
330 TRANSAMINASES INCREASED 26 0.0012
331 GAIT INABILITY 39 0.0012
332 PARAESTHESIA 183 0.0012
333 BLOOD CREATININE ABNORMAL 4 0.0012
334 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
335 JOINT SWELLING 137 0.0011
336 BLOOD POTASSIUM ABNORMAL 3 0.0011
337 DYSARTHRIA 42 0.0011
338 ANAL INCONTINENCE 10 0.0011
339 EAR CONGESTION 3 0.0011
340 ANAEMIA 209 0.0011
341 LOWER LIMB FRACTURE 21 0.0011
342 ERECTILE DYSFUNCTION 28 0.0011
343 CONDITION AGGRAVATED 330 0.0011
344 MOTOR DYSFUNCTION 11 0.0011
345 ABDOMINAL PAIN UPPER 221 0.0011
346 WALKING AID USER 7 0.0011
347 NEUTROPHIL COUNT ABNORMAL 3 0.0011
348 PERIPHERAL SWELLING 163 0.0011
349 WEIGHT FLUCTUATION 11 0.0011
350 PLEURAL EFFUSION 63 0.0010
351 ERUCTATION 20 0.0010
352 PRODUCT LABEL CONFUSION 6 0.0010
353 BLOOD IRON DECREASED 12 0.0010
354 CATARACT OPERATION 6 0.0010
355 HAEMOPTYSIS 28 0.0010
356 URINE ANALYSIS ABNORMAL 3 0.0010
357 MYOSITIS 9 0.0010
358 BLOOD PRESSURE FLUCTUATION 24 0.0010
359 NORMOCHROMIC NORMOCYTIC ANAEMIA 3 0.0010
360 CENTRAL VENOUS CATHETERISATION 3 0.0010
361 BONE MARROW DISORDER 3 0.0010
362 FOOT DEFORMITY 11 0.0010
363 SPINAL FUSION SURGERY 4 0.0010
364 JOINT INJURY 21 0.0010
365 TREATMENT FAILURE 81 0.0010
366 ABNORMAL FAECES 8 0.0010
367 OEDEMA PERIPHERAL 119 0.0010
368 RESPIRATORY DISORDER 29 0.0010
369 MULTIPLE-DRUG RESISTANCE 3 0.0010
370 MOVEMENT DISORDER 31 0.0010
371 OEDEMA 52 0.0010
372 HEPATIC CIRRHOSIS 18 0.0010
373 JOINT STIFFNESS 25 0.0010
374 POLYARTHRITIS 5 0.0009
375 RED BLOOD CELL COUNT DECREASED 27 0.0009
376 RASH MACULO-PAPULAR 21 0.0009
377 HEPATOTOXICITY 21 0.0009
378 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
379 INJURY 66 0.0009
380 VOMITING 432 0.0009
381 BODY TEMPERATURE DECREASED 9 0.0009
382 URTICARIA 153 0.0009
383 SPINAL OSTEOARTHRITIS 8 0.0009
384 ADVERSE REACTION 12 0.0009
385 MUSCULOSKELETAL CHEST PAIN 14 0.0009
386 DIVERTICULITIS 25 0.0009
387 NERVE INJURY 10 0.0009
388 RHINITIS ALLERGIC 4 0.0009
389 PLANTAR FASCIITIS 3 0.0009
390 CONFUSIONAL STATE 144 0.0009
391 CLOSTRIDIAL INFECTION 3 0.0009
392 VASCULAR DEVICE INFECTION 4 0.0009
393 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
394 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
395 POOR VENOUS ACCESS 9 0.0009
396 LOCALISED OEDEMA 4 0.0009
397 FEELING OF DESPAIR 4 0.0009
398 HAEMATOCRIT DECREASED 17 0.0009
399 DIARRHOEA HAEMORRHAGIC 8 0.0009
400 JOINT DISLOCATION 9 0.0009
401 UPPER RESPIRATORY TRACT INFECTION 39 0.0008
402 DRY EYE 42 0.0008
403 SLEEP APNOEA SYNDROME 16 0.0008
404 HYPERTENSION 177 0.0008
405 HAEMOGLOBIN DECREASED 85 0.0008
406 PRODUCT USE IN UNAPPROVED INDICATION 205 0.0008
407 FINGER DEFORMITY 4 0.0008
408 DIZZINESS POSTURAL 8 0.0008
409 ABDOMINAL DISCOMFORT 137 0.0008
410 HYPOMANIA 3 0.0008
411 GASTROINTESTINAL DISORDER 73 0.0008
412 BLOOD PRESSURE DIASTOLIC DECREASED 6 0.0008
413 NASAL POLYPS 4 0.0008
414 ACUTE PSYCHOSIS 2 0.0008
415 GENERAL SYMPTOM 6 0.0008
416 BLOOD CALCIUM DECREASED 9 0.0008
417 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
418 HYPOMAGNESAEMIA 11 0.0008
419 THYROID MASS 3 0.0008
420 MUSCLE SPASMS 143 0.0008
421 NEUROPATHY PERIPHERAL 74 0.0008
422 BLOOD UREA INCREASED 13 0.0008
423 RHINOVIRUS INFECTION 3 0.0008
424 UNDERDOSE 56 0.0008
425 TONSILLITIS 4 0.0008
426 PROSTATOMEGALY 3 0.0008
427 ORAL CANDIDIASIS 10 0.0008
428 APPETITE DISORDER 5 0.0008
429 DISCOMFORT 46 0.0008
430 PREMATURE DELIVERY 12 0.0008
431 CEREBRAL ATROPHY 3 0.0008
432 DELIRIUM 26 0.0007
433 SKIN PAPILLOMA 3 0.0007
434 ALCOHOL POISONING 2 0.0007
435 HYPOPHAGIA 19 0.0007
436 FAECES DISCOLOURED 16 0.0007
437 POLLAKIURIA 30 0.0007
438 HYPERTRANSAMINASAEMIA 5 0.0007
439 NASOPHARYNGITIS 131 0.0007
440 STATUS EPILEPTICUS 8 0.0007
441 BUNDLE BRANCH BLOCK LEFT 3 0.0007
442 HYPERTONIA 4 0.0007
443 HORDEOLUM 3 0.0007
444 VAGINAL DISCHARGE 7 0.0007
445 LYMPHOCYTE COUNT DECREASED 12 0.0007
446 ABDOMINAL ABSCESS 3 0.0007
447 SINUS HEADACHE 4 0.0007
448 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 5 0.0007
449 HEART RATE IRREGULAR 15 0.0007
450 OPTIC NEURITIS 6 0.0007
451 BRADYCARDIA 35 0.0007
452 THERAPEUTIC PRODUCT EFFECT DELAYED 3 0.0007
453 ALOPECIA 129 0.0007
454 HYPOXIA 23 0.0007
455 ASTHENIA 245 0.0007
456 DECREASED APPETITE 150 0.0006
457 INFUSION SITE EXTRAVASATION 4 0.0006
458 NASAL DRYNESS 4 0.0006
459 AFFECTIVE DISORDER 5 0.0006
460 HYPERSENSITIVITY 118 0.0006
461 SARCOIDOSIS 3 0.0006
462 CORONARY ARTERY DISEASE 19 0.0006
463 PARAESTHESIA ORAL 9 0.0006
464 STILLBIRTH 3 0.0006
465 FRUSTRATION TOLERANCE DECREASED 5 0.0006
466 PRODUCT QUALITY ISSUE 84 0.0006
467 APATHY 9 0.0006
468 PAIN 373 0.0006
469 IMMUNODEFICIENCY 9 0.0006
470 BLOOD BILIRUBIN INCREASED 16 0.0006
471 MACULAR DEGENERATION 7 0.0006
472 PHLEBITIS 3 0.0006
473 MATERNAL EXPOSURE BEFORE PREGNANCY 4 0.0006
474 HYPOCALCAEMIA 11 0.0006
475 DELUSION 9 0.0006
476 BALANCE DISORDER 50 0.0006
477 ADRENAL INSUFFICIENCY 7 0.0006
478 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
479 RENAL IMPAIRMENT 48 0.0006
480 SERUM FERRITIN INCREASED 3 0.0006
481 PHARYNGOLARYNGEAL PAIN 3 0.0006
482 MUSCULAR WEAKNESS 64 0.0006
483 DIVERTICULUM 4 0.0006
484 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 40 0.0006
485 DYSPEPSIA 55 0.0006
486 RECTAL HAEMORRHAGE 24 0.0006
487 WEIGHT INCREASED 125 0.0006
488 DEPRESSION 127 0.0006
489 ANAL ABSCESS 3 0.0006
490 GINGIVITIS 3 0.0006
491 CARDIOVASCULAR DISORDER 14 0.0006
492 LIMB DISCOMFORT 17 0.0005
493 NAUSEA 433 0.0005
494 CARDIOMYOPATHY 8 0.0005
495 CEREBRAL DISORDER 4 0.0005
496 VISUAL IMPAIRMENT 67 0.0005
497 ASTHMA 61 0.0005
498 INTRACRANIAL PRESSURE INCREASED 3 0.0005
499 PYREXIA 186 0.0005
500 PRODUCT LEAKAGE 3 0.0005
501 ROAD TRAFFIC ACCIDENT 22 0.0005
502 OFF LABEL USE 458 0.0005
503 HIP ARTHROPLASTY 8 0.0005
504 LIPASE INCREASED 4 0.0005
505 DISSOCIATION 4 0.0005
506 PROCEDURAL COMPLICATION 4 0.0005
507 WHITE BLOOD CELL COUNT INCREASED 20 0.0005
508 ATRIOVENTRICULAR BLOCK 4 0.0005
509 SINUS BRADYCARDIA 5 0.0005
510 COLITIS ULCERATIVE 23 0.0005
511 HEADACHE 321 0.0005
512 MULTIPLE ALLERGIES 4 0.0005
513 LYMPHADENOPATHY 18 0.0005
514 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
515 GINGIVAL PAIN 4 0.0005
516 PNEUMONIA 162 0.0005
517 ARTHRALGIA 208 0.0005
518 BACK PAIN 116 0.0005
519 TYPE 1 DIABETES MELLITUS 3 0.0005
520 LIVER DISORDER 22 0.0005
521 AMNESIA 32 0.0005
522 CARDIOMEGALY 6 0.0005
523 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
524 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
525 DIZZINESS 241 0.0005
526 THINKING ABNORMAL 9 0.0005
527 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
528 DRUG-INDUCED LIVER INJURY 15 0.0005
529 BRAIN OEDEMA 6 0.0005
530 KNEE ARTHROPLASTY 10 0.0005
531 FLUID RETENTION 24 0.0005
532 ANXIETY 134 0.0005
533 HYPOTHYROIDISM 15 0.0005
534 OROPHARYNGEAL PAIN 43 0.0005
535 POOR QUALITY SLEEP 10 0.0005
536 PARANOIA 8 0.0005
537 RASH PRURITIC 25 0.0005
538 OESOPHAGITIS 5 0.0005
539 TOOTH INFECTION 6 0.0005
540 LOCALISED INFECTION 11 0.0005
541 MULTIPLE SCLEROSIS RELAPSE 31 0.0005
542 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
543 EYE HAEMORRHAGE 6 0.0004
544 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 81 0.0004
545 COLITIS 17 0.0004
546 CHROMATURIA 10 0.0004
547 DIARRHOEA 284 0.0004
548 BLOOD TESTOSTERONE DECREASED 3 0.0004
549 ONYCHOCLASIS 3 0.0004
550 PNEUMONIA BACTERIAL 4 0.0004
551 LETHARGY 25 0.0004
552 DROOLING 3 0.0004
553 ADVERSE EVENT 40 0.0004
554 VASCULITIS 5 0.0004
555 DEFAECATION URGENCY 3 0.0004
556 SEASONAL ALLERGY 6 0.0004
557 RESPIRATORY TRACT INFECTION 11 0.0004
558 PRODUCT SUPPLY ISSUE 3 0.0004
559 MUSCLE RIGIDITY 5 0.0004
560 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
561 POLYNEUROPATHY 5 0.0004
562 ELECTROCARDIOGRAM QT PROLONGED 15 0.0004
563 TONGUE DISORDER 3 0.0004
564 HYPERTHYROIDISM 6 0.0004
565 HYPERGLYCAEMIA 15 0.0004
566 DYSPNOEA 233 0.0004
567 PARKINSONISM 4 0.0004
568 COELIAC DISEASE 4 0.0004
569 DYSURIA 15 0.0004
570 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
571 THERAPY CHANGE 4 0.0004
572 SMALL INTESTINAL OBSTRUCTION 5 0.0004
573 URINARY INCONTINENCE 12 0.0004
574 FLUSHING 41 0.0004
575 PHARYNGITIS 5 0.0004
576 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
577 INSOMNIA 107 0.0004
578 EOSINOPHILIA 7 0.0004
579 FATIGUE 311 0.0004
580 PEMPHIGOID 3 0.0004
581 TOOTH ABSCESS 4 0.0004
582 SLUGGISHNESS 4 0.0004
583 MATERNAL DRUGS AFFECTING FOETUS 3 0.0004
584 VIRAL INFECTION 13 0.0004
585 INFUSION SITE PAIN 5 0.0004
586 PAIN IN EXTREMITY 113 0.0004
587 NODULE 5 0.0004
588 BRAIN FOG 6 0.0004
589 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
590 TRANSFUSION 4 0.0004
591 HEAD INJURY 12 0.0004
592 TRICUSPID VALVE INCOMPETENCE 3 0.0004
593 CLOSTRIDIUM DIFFICILE COLITIS 4 0.0004
594 EAR INFECTION 10 0.0004
595 QUALITY OF LIFE DECREASED 5 0.0004
596 BREAST CANCER METASTATIC 4 0.0004
597 STENT PLACEMENT 3 0.0004
598 DYSPNOEA EXERTIONAL 14 0.0004
599 RASH 162 0.0004
600 SINUS CONGESTION 5 0.0004
601 AKATHISIA 5 0.0004
602 INFECTION 53 0.0004
603 CHOLELITHIASIS 12 0.0004
604 HYPERAESTHESIA 3 0.0004
605 LACRIMATION INCREASED 11 0.0004
606 RESPIRATORY DISTRESS 10 0.0004
607 MALNUTRITION 4 0.0004
608 ANGIOPATHY 2 0.0004
609 GLYCOSYLATED HAEMOGLOBIN INCREASED 9 0.0004
610 THERAPY NON-RESPONDER 16 0.0004
611 INFUSION SITE ERYTHEMA 3 0.0004
612 RHINORRHOEA 23 0.0004
613 FACE OEDEMA 6 0.0004
614 GAIT DISTURBANCE 68 0.0004
615 HEMIPARESIS 6 0.0004
616 DISABILITY 7 0.0004
617 SINUS DISORDER 7 0.0004
618 HEPATITIS 9 0.0004
619 UPPER LIMB FRACTURE 7 0.0004
620 DERMATITIS CONTACT 4 0.0004
621 ANURIA 3 0.0003
622 NEOPLASM 4 0.0003
623 BLOOD MAGNESIUM DECREASED 3 0.0003
624 FULL BLOOD COUNT DECREASED 7 0.0003
625 ILL-DEFINED DISORDER 21 0.0003
626 FOETAL EXPOSURE DURING PREGNANCY 28 0.0003
627 GASTROENTERITIS 5 0.0003
628 SINUSITIS 35 0.0003
629 TUMOUR LYSIS SYNDROME 3 0.0003
630 PANCREATITIS 18 0.0003
631 COVID-19 PNEUMONIA 4 0.0003
632 PLATELET COUNT DECREASED 36 0.0003
633 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
634 BACTERAEMIA 4 0.0003
635 THIRST 6 0.0003
636 HYPERHIDROSIS 43 0.0003
637 PNEUMONITIS 9 0.0003
638 HYPOGLYCAEMIA 16 0.0003
639 SKIN DISCOLOURATION 15 0.0003
640 PROCEDURAL PAIN 9 0.0003
641 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
642 HYPERCALCAEMIA 4 0.0003
643 PRODUCT DOSE OMISSION ISSUE 95 0.0003
644 CONTUSION 31 0.0003
645 AGEUSIA 8 0.0003
646 THERAPY PARTIAL RESPONDER 5 0.0003
647 SEIZURE 37 0.0003
648 DYSKINESIA 13 0.0003
649 SECRETION DISCHARGE 4 0.0003
650 SQUAMOUS CELL CARCINOMA 3 0.0003
651 FLATULENCE 18 0.0003
652 CHILLS 37 0.0003
653 DISTURBANCE IN ATTENTION 17 0.0003
654 INJECTION SITE IRRITATION 4 0.0003
655 ABSCESS 5 0.0003
656 HEART RATE DECREASED 11 0.0003
657 HIATUS HERNIA 4 0.0003
658 BACK DISORDER 5 0.0003
659 EPISTAXIS 23 0.0003
660 PHARYNGEAL SWELLING 3 0.0003
661 DEAFNESS 8 0.0003
662 HEPATOMEGALY 3 0.0003
663 VITREOUS FLOATERS 3 0.0003
664 INFLUENZA LIKE ILLNESS 25 0.0003
665 HOSPICE CARE 3 0.0003
666 LIGAMENT SPRAIN 3 0.0003
667 HYPOKALAEMIA 14 0.0003
668 DISORIENTATION 12 0.0003
669 CHEST PAIN 56 0.0003
670 DRUG LEVEL INCREASED 5 0.0003
671 ERYTHEMA 62 0.0003
672 BLOOD PRESSURE DECREASED 20 0.0003
673 WEIGHT DECREASED 84 0.0003
674 CYTOMEGALOVIRUS INFECTION 5 0.0003
675 ADVERSE DRUG REACTION 27 0.0003
676 PREGNANCY 6 0.0003
677 BLOOD POTASSIUM DECREASED 9 0.0003
678 TOXIC SKIN ERUPTION 3 0.0003
679 PRODUCT PHYSICAL ISSUE 6 0.0003
680 EMPHYSEMA 3 0.0003
681 CANDIDA INFECTION 5 0.0003
682 FEEDING DISORDER 6 0.0003
683 BODY TEMPERATURE INCREASED 6 0.0003
684 PRODUCTIVE COUGH 14 0.0003
685 NEUTROPHIL COUNT INCREASED 3 0.0003
686 GINGIVAL BLEEDING 4 0.0003
687 EAR DISCOMFORT 3 0.0003
688 RIB FRACTURE 6 0.0003
689 FALL 97 0.0003
690 PULMONARY OEDEMA 13 0.0003
691 HYPERBILIRUBINAEMIA 3 0.0003
692 TREMOR 48 0.0003
693 OXYGEN SATURATION DECREASED 16 0.0003
694 BRONCHITIS 21 0.0003
695 TINNITUS 13 0.0003
696 COUGH 79 0.0003
697 BREAST PAIN 3 0.0003
698 BLOOD PRESSURE INCREASED 43 0.0003
699 INTENTIONAL DOSE OMISSION 8 0.0003
700 HOSPITALISATION 43 0.0003
701 IMPAIRED QUALITY OF LIFE 4 0.0003
702 DECREASED ACTIVITY 3 0.0003
703 PRURITUS GENERALISED 6 0.0003
704 GASTROENTERITIS VIRAL 5 0.0003
705 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
706 SKIN LACERATION 3 0.0003
707 URINARY TRACT INFECTION 47 0.0003
708 GASTROINTESTINAL PAIN 3 0.0003
709 DENTAL CARIES 3 0.0003
710 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 13 0.0003
711 PRURITUS 104 0.0003
712 NEUTROPHIL COUNT DECREASED 11 0.0003
713 SKIN INFECTION 3 0.0003
714 REBOUND EFFECT 3 0.0003
715 HALLUCINATION 20 0.0003
716 BLOOD SODIUM DECREASED 5 0.0003
717 FOOT FRACTURE 5 0.0003
718 WHITE BLOOD CELL COUNT DECREASED 28 0.0003
719 ELECTROLYTE IMBALANCE 3 0.0003
720 CAESAREAN SECTION 3 0.0003
721 EJECTION FRACTION DECREASED 4 0.0003
722 APNOEA 2 0.0003
723 DYSPHONIA 15 0.0003
724 NERVOUS SYSTEM DISORDER 8 0.0003
725 FEBRILE NEUTROPENIA 17 0.0003
726 SWOLLEN TONGUE 8 0.0003
727 BONE PAIN 15 0.0003
728 SEXUAL DYSFUNCTION 3 0.0003
729 SEPTIC SHOCK 11 0.0003
730 CATARACT 15 0.0003
731 RESPIRATORY TRACT CONGESTION 4 0.0003
732 CYSTITIS 8 0.0003
733 WRIST FRACTURE 3 0.0003
734 PRODUCT USE ISSUE 47 0.0002
735 SPINAL FRACTURE 5 0.0002
736 MYALGIA 42 0.0002
737 SCHIZOPHRENIA 3 0.0002
738 BONE MARROW FAILURE 5 0.0002
739 ACCIDENTAL OVERDOSE 9 0.0002
740 BLINDNESS 10 0.0002
741 CYTOPENIA 3 0.0002
742 ENCEPHALOPATHY 6 0.0002
743 INJECTION SITE WARMTH 5 0.0002
744 TENDON RUPTURE 3 0.0002
745 PERITONITIS 5 0.0002
746 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
747 HALLUCINATION, VISUAL 5 0.0002
748 HEPATIC CYTOLYSIS 3 0.0002
749 INTRAOCULAR PRESSURE INCREASED 3 0.0002
750 HAEMATURIA 8 0.0002
751 ROTATOR CUFF SYNDROME 3 0.0002
752 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 6 0.0002
753 INFLUENZA 26 0.0002
754 HEART RATE INCREASED 23 0.0002
755 DIPLOPIA 6 0.0002
756 PALPITATIONS 27 0.0002
757 PLATELET COUNT INCREASED 3 0.0002
758 NEOPLASM PROGRESSION 8 0.0002
759 NEUROTOXICITY 4 0.0002
760 MALAISE 100 0.0002
761 SARS-COV-2 TEST POSITIVE 3 0.0002
762 EMOTIONAL DISORDER 7 0.0002
763 CHRONIC KIDNEY DISEASE 17 0.0002
764 SNEEZING 5 0.0002
765 DRUG INEFFECTIVE 292 0.0002
766 DRUG TOXICITY 3 0.0002
767 RESTLESS LEGS SYNDROME 4 0.0002
768 BONE DISORDER 4 0.0002
769 PANIC ATTACK 8 0.0002
770 LOSS OF CONSCIOUSNESS 28 0.0002
771 VISION BLURRED 30 0.0002
772 PERIPHERAL COLDNESS 3 0.0002
773 NEPHROLITHIASIS 10 0.0002
774 COORDINATION ABNORMAL 3 0.0002
775 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
776 MIDDLE INSOMNIA 4 0.0002
777 BURNING SENSATION 15 0.0002
778 INTESTINAL OBSTRUCTION 8 0.0002
779 PRODUCT PRESCRIBING ERROR 5 0.0002
780 PARALYSIS 3 0.0002
781 CHOLESTASIS 4 0.0002
782 DRUG INTERACTION 33 0.0002
783 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
784 ANGER 7 0.0002
785 LIVER FUNCTION TEST ABNORMAL 6 0.0002
786 ILLNESS 21 0.0002
787 ARTHRITIS 16 0.0002
788 LABORATORY TEST ABNORMAL 6 0.0002
789 PSYCHOTIC DISORDER 6 0.0002
790 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
791 LEUKOPENIA 10 0.0002
792 SWELLING FACE 13 0.0002
793 COVID-19 35 0.0002
794 PREMATURE BABY 6 0.0002
795 HEPATIC FAILURE 6 0.0002
796 PRODUCT ADMINISTRATION ERROR 4 0.0002
797 INJECTION SITE SWELLING 15 0.0002
798 INJECTION SITE RASH 6 0.0002
799 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
800 EYE PAIN 11 0.0002
801 RASH GENERALISED 5 0.0002
802 BASAL CELL CARCINOMA 3 0.0002
803 MUCOSAL INFLAMMATION 5 0.0002
804 DERMATITIS 4 0.0002
805 AGITATION 14 0.0002
806 WITHDRAWAL SYNDROME 8 0.0002
807 MOUTH ULCERATION 4 0.0002
808 INJECTION SITE MASS 7 0.0002
809 PNEUMOTHORAX 3 0.0002
810 INJECTION SITE REACTION 13 0.0002
811 HALLUCINATION, AUDITORY 3 0.0002
812 MOOD SWINGS 6 0.0002
813 RETCHING 4 0.0002
814 BLOOD GLUCOSE DECREASED 9 0.0002
815 HYPOACUSIS 8 0.0002
816 DRUG EFFECT DECREASED 10 0.0002
817 INJECTION SITE ERYTHEMA 23 0.0002
818 LACTIC ACIDOSIS 6 0.0002
819 ATRIAL FIBRILLATION 18 0.0002
820 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
821 NEUTROPENIA 25 0.0002
822 MENTAL DISORDER 8 0.0002
823 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
824 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
825 IRRITABILITY 11 0.0002
826 STAPHYLOCOCCAL INFECTION 6 0.0002
827 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
828 DRY SKIN 24 0.0002
829 FEELING COLD 5 0.0002
830 DEMENTIA 5 0.0002
831 THROMBOCYTOPENIA 20 0.0002
832 CELLULITIS 9 0.0002
833 PANCREATITIS ACUTE 4 0.0002
834 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
835 DEATH 153 0.0002
836 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
837 PAIN IN JAW 5 0.0002
838 HYPOTENSION 35 0.0002
839 HYPERSOMNIA 5 0.0002
840 MUSCULOSKELETAL DISCOMFORT 3 0.0002
841 MULTI-ORGAN FAILURE 3 0.0002
842 NEEDLE ISSUE 5 0.0002
843 DYSSTASIA 5 0.0002
844 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
845 METASTASES TO LIVER 3 0.0002
846 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
847 DEEP VEIN THROMBOSIS 11 0.0002
848 TACHYCARDIA 15 0.0002
849 GALLBLADDER DISORDER 3 0.0002
850 LEUKOCYTOSIS 3 0.0002
851 TOOTHACHE 3 0.0002
852 OSTEOMYELITIS 3 0.0002
853 APHASIA 5 0.0002
854 DEHYDRATION 22 0.0002
855 THERAPEUTIC RESPONSE DECREASED 10 0.0002
856 RESPIRATORY FAILURE 12 0.0002
857 TREATMENT NONCOMPLIANCE 9 0.0002
858 RESTLESSNESS 6 0.0002
859 MEDICATION ERROR 9 0.0002
860 EYE SWELLING 6 0.0002
861 AGGRESSION 8 0.0002
862 ANGIOEDEMA 7 0.0002
863 PRODUCT COMPLAINT 4 0.0002
864 GASTRIC ULCER 3 0.0002
865 HAEMATEMESIS 4 0.0002
866 SEROTONIN SYNDROME 3 0.0002
867 ACUTE RESPIRATORY FAILURE 3 0.0002
868 ANOREXIA 2 0.0002
869 SKIN ULCER 4 0.0002
870 FEELING ABNORMAL 37 0.0002
871 HAEMATOMA 4 0.0002
872 HAEMORRHOIDS 3 0.0002
873 NASAL CONGESTION 9 0.0002
874 PSORIASIS 20 0.0002
875 SEDATION 4 0.0002
876 FUNGAL INFECTION 5 0.0001
877 CARDIAC FAILURE CONGESTIVE 12 0.0001
878 MYOCARDIAL INFARCTION 26 0.0001
879 JAUNDICE 4 0.0001
880 BLOOD GLUCOSE INCREASED 28 0.0001
881 OCULAR HYPERAEMIA 7 0.0001
882 LIMB INJURY 4 0.0001
883 HOT FLUSH 11 0.0001
884 HAEMATOCHEZIA 8 0.0001
885 PULMONARY HYPERTENSION 3 0.0001
886 DEVICE USE ERROR 5 0.0001
887 ACUTE KIDNEY INJURY 22 0.0001
888 APHONIA 2 0.0001
889 RASH MACULAR 5 0.0001
890 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
891 IMPAIRED WORK ABILITY 3 0.0001
892 ANGINA PECTORIS 4 0.0001
893 HERPES ZOSTER 8 0.0001
894 PRODUCT DISPENSING ERROR 3 0.0001
895 CHEST DISCOMFORT 14 0.0001
896 DISEASE PROGRESSION 16 0.0001
897 STEVENS-JOHNSON SYNDROME 3 0.0001
898 INJECTION SITE PRURITUS 9 0.0001
899 ORAL PAIN 3 0.0001
900 THROAT IRRITATION 6 0.0001
901 DEPRESSED MOOD 7 0.0001
902 PRODUCT AVAILABILITY ISSUE 3 0.0001
903 MUSCLE TWITCHING 3 0.0001
904 PERICARDIAL EFFUSION 3 0.0001
905 ANKLE FRACTURE 2 0.0001
906 COGNITIVE DISORDER 6 0.0001
907 DYSPHAGIA 12 0.0001
908 THERAPY INTERRUPTED 9 0.0001
909 PANCYTOPENIA 7 0.0001
910 ABORTION SPONTANEOUS 5 0.0001
911 MENTAL IMPAIRMENT 3 0.0001
912 INJECTION SITE URTICARIA 3 0.0001
913 LUNG NEOPLASM MALIGNANT 5 0.0001
914 RHABDOMYOLYSIS 5 0.0001
915 UNEVALUABLE EVENT 9 0.0001
916 ABDOMINAL PAIN LOWER 3 0.0001
917 UNRESPONSIVE TO STIMULI 3 0.0001
918 NIGHTMARE 4 0.0001
919 SUICIDE ATTEMPT 7 0.0001
920 VAGINAL HAEMORRHAGE 5 0.0001
921 DEVICE DISLOCATION 5 0.0001
922 HYPERKALAEMIA 4 0.0001
923 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
924 FEAR 3 0.0001
925 THROAT TIGHTNESS 3 0.0001
926 PALLOR 3 0.0001
927 CRYING 4 0.0001
928 ANAPHYLACTIC REACTION 6 0.0001
929 DYSGEUSIA 8 0.0001
930 AGRANULOCYTOSIS 2 0.0001
931 HEPATIC FUNCTION ABNORMAL 4 0.0001
932 RENAL FAILURE 14 0.0001
933 EYE IRRITATION 6 0.0001
934 RENAL INJURY 3 0.0001
935 CARDIAC FAILURE 8 0.0001
936 VERTIGO 6 0.0001
937 DRUG ADMINISTRATION ERROR 3 0.0001
938 CARDIAC DISORDER 9 0.0001
939 ECZEMA 5 0.0001
940 SPEECH DISORDER 5 0.0001
941 METABOLIC ACIDOSIS 3 0.0001
942 EYE DISORDER 3 0.0001
943 APPLICATION SITE PAIN 2 0.0001
944 SKIN DISORDER 3 0.0001
945 DEVICE ISSUE 8 0.0001
946 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
947 APPLICATION SITE PRURITUS 2 0.0001
948 GASTRIC DISORDER 3 0.0001
949 SUICIDAL IDEATION 8 0.0001
950 PRODUCT SUBSTITUTION ISSUE 5 0.0001
951 HAEMORRHAGE 9 0.0001
952 RENAL DISORDER 4 0.0001
953 DEVICE MALFUNCTION 6 0.0001
954 CEREBRAL HAEMORRHAGE 3 0.0001
955 SKIN EXFOLIATION 7 0.0001
956 NO ADVERSE EVENT 15 0.0001
957 ABASIA 2 0.0001
958 INJECTION SITE PAIN 24 0.0001
959 THERAPY CESSATION 4 0.0001
960 PLASMA CELL MYELOMA 3 0.0001
961 NERVOUSNESS 4 0.0001
962 ABNORMAL BEHAVIOUR 3 0.0001
963 INJECTION SITE BRUISING 6 0.0001
964 NEOPLASM MALIGNANT 5 0.0001
965 EMOTIONAL DISTRESS 9 0.0001
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 15 0.0001
967 CARDIAC ARREST 6 0.0001
968 ABNORMAL DREAMS 2 0.0001
969 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
970 CARDIO-RESPIRATORY ARREST 3 0.0001
971 PRODUCT STORAGE ERROR 6 0.0001
972 TOXICITY TO VARIOUS AGENTS 11 0.0001
973 OVERDOSE 14 0.0001
974 DISEASE RECURRENCE 3 0.0001
975 MULTIPLE SCLEROSIS 3 0.0001
976 INTERSTITIAL LUNG DISEASE 3 0.0001
977 INCORRECT DOSE ADMINISTERED 14 0.0001
978 PRODUCT DOSE OMISSION 4 0.0001
979 DRUG DOSE OMISSION 10 0.0001
980 CONVULSION 3 0.0001
981 INJECTION SITE HAEMORRHAGE 4 0.0001
982 SYNCOPE 5 0.0000
983 BREAST CANCER 4 0.0000
984 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
985 SKIN BURNING SENSATION 3 0.0000
986 DRUG WITHDRAWAL SYNDROME 3 0.0000
987 CEREBROVASCULAR ACCIDENT 5 0.0000